Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


     
   
Prozac Used To Treat Kleptomania

NEW YORK, Feb 22 (Reuters Health) -- Kleptomania, the psychiatric disorder characterized by an overwhelming urge to steal objects, can be treated with a combination of Prozac -- or similar drugs -- and psychotherapy, a study suggests.

The treatment relieved the symptoms of kleptomania in five patients within 5 months, according to a report in the January/February issue of Clinical Neuropharmacology. After that point, the doctors reduced the dosage of medication, although this led to a return of the urge to steal in some patients, according to Dr. Elie Lepkifker and colleagues at Chaim Sheba Medical Center in Tel HaShomer, Israel.

"In one case, the discontinuation of the medication repeatedly led to the resurgence of the kleptomanic behavior," according to the report. The patients were given either fluoxetine (Prozac) or paroxetine (Paxil).

It is not clear why such serotonin reuptake inhibitors can help relieve the symptoms of Kleptomania, but the researchers suggest two possible explanations.

First, they speculate, kleptomania may be one of the obsessive-compulsive disorders, which have been treated successfully with serotonin reuptake inhibitors.

Alternatively, the findings suggest that kleptomania may result from a fall in the brain's level of the neurotransmitter serotonin, which is corrected by the drug treatment.

Additional studies will be required to confirm the benefits of serotonin reuptake inhibitors in patients with kleptomania as well as to better understand the mechanisms underlying these benefits, the authors conclude.

SOURCE: Clinical Neuropharmacology 1999;22:40-43.


DISCUSSION
See what PersonalMD members have to say about this article.
 

 
 

 

Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health